Dyloject
NDA- Indications
- Post-operative pain
Company intelligence / Profile preview
Javelin Pharmaceuticals
Cambridge, Massachusetts, United Statesjavelinpharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- NDA
01
Overview
Javelin developed differentiated acute pain control drugs with improved safety profiles and novel delivery methods. Its lead product Dyloject™ (injectable diclofenac) was approved in Europe; Ereska™ (intranasal ketamine) and Rylomine™ (intranasal morphine) were in advanced clinical trials at the time of acquisition. Clinical data showed rapid onset of action with reduced side effects for intranasal formulations
- Therapeutic areas
- OtherNeurology
- Modalities
- Small moleculesnovel drug formulations
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major disclosed pharma partnerships pre-acquisition; investors included Hospira as strategic partner/investor before full acquisition
Beyond the preview
Go deeper on Javelin Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Javelin Pharmaceuticals.